How the Supercluster fuels Immune Engineering research

In a recent interview with BioPharm International, Dr Stephen Wilson, CEO and Executive Director of the Botnar Institute of Immune Engineering (BIIE) highlights why the institute specifically chose the Basel Area as the location for its new research facility.

BIIE combines academic discovery with a consistent focus on translation, particularly addressing the needs of children and adolescents in low- and middle-income countries. That mission makes the environment around its research especially important.

As Dr. Stephen Wilson explains, immune engineering is still an evolving scientific field, and the different steps of the translation process often cannot be managed independently by a single organization. Moving discoveries toward real-world applications therefore depends on access to complementary expertise, partners and infrastructure.

The Basel Area Life Sciences Supercluster’s long-established biomedical innovation ecosystem brings research institutes, universities, entrepreneurial companies and global pharmaceutical organizations into close proximity. The region’s strong academic connections, including with ETH Zurich, add another layer of expertise to this environment. For BIIE, this concentration provides access to complementary capabilities and potential collaborators across discovery and industry, especially with translational research without having to build every capability within its own organization.

BIIE’s decision to establish its new facility in the Switzerland Innovation Park Basel Area highlights a broader consideration for research organizations choosing where to grow: when scientific progress depends on specialized expertise and collaboration across the translation process, the right ecosystem can help remove barriers between discovery and application.

Read the article: Basel’s Innovation Ecosystem Fuels New Immune Engineering Institute | BioPharm International